Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

OptimizeRx (OPRX) Net Income towards Common Stockholders (2016 - 2026)

OptimizeRx's Net Income towards Common Stockholders history spans 16 years, with the latest figure at $5.0 million for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders rose 6535.9% to $5.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.1 million, a 125.52% increase, with the full-year FY2025 number at $5.1 million, up 125.52% from a year prior.
  • Net Income towards Common Stockholders hit $5.0 million in Q4 2025 for OptimizeRx, up from $779000.0 in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for OPRX hit a ceiling of $5.0 million in Q4 2025 and a floor of -$11.7 million in Q4 2023.
  • Historically, Net Income towards Common Stockholders has averaged -$2.6 million across 5 years, with a median of -$2.5 million in 2023.
  • Biggest five-year swings in Net Income towards Common Stockholders: plummeted 8790.01% in 2022 and later skyrocketed 6535.9% in 2025.
  • Tracing OPRX's Net Income towards Common Stockholders over 5 years: stood at $623462.0 in 2021, then crashed by 152.26% to -$325836.0 in 2022, then tumbled by 3503.04% to -$11.7 million in 2023, then surged by 99.34% to -$78000.0 in 2024, then skyrocketed by 6535.9% to $5.0 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for OPRX at $5.0 million in Q4 2025, $779000.0 in Q3 2025, and $1.5 million in Q2 2025.